Marie Alexandre

Université Paris Est Créteil
Creteil, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trial.

Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trial.

Journal: PLoS neglected tropical diseases

Published: September 22, 2025

Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates.

Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates.

Journal: EBioMedicine

Published: September 10, 2025

Defining Optimal Vaccine Features for Pandemic Preparedness: an Individual-Based Model Bridging Within- and Between-Host Dynamics.

Defining Optimal Vaccine Features for Pandemic Preparedness: an Individual-Based Model Bridging Within- and Between-Host Dynamics.

Journal: Bulletin of mathematical biology

Published: August 18, 2025

Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial.

Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial.

Journal: Emerging microbes & infections

Published: November 19, 2024

Definition of Virological Endpoints Improving the Design of HIV Cure Strategies Using Analytical Antiretroviral Treatment Interruption.

Definition of Virological Endpoints Improving the Design of HIV Cure Strategies Using Analytical Antiretroviral Treatment Interruption.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: January 26, 2024

Prediction of long-term humoral response induced by the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola.

Prediction of long-term humoral response induced by the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola.

Journal: NPJ vaccines

Published: March 23, 2023

Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates.

Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates.

Journal: PLoS computational biology

Published: November 08, 2022

Within-host models of SARS-CoV-2: What can it teach us on the biological factors driving virus pathogenesis and transmission?

Within-host models of SARS-CoV-2: What can it teach us on the biological factors driving virus pathogenesis and transmission?

Journal: Anaesthesia, critical care & pain medicine

Published: March 05, 2022

Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection.

Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection.

Journal: eLife

Published: November 09, 2021

Between-group comparison of area under the curve in clinical trials with censored follow-up: Application to HIV therapeutic vaccines.

Between-group comparison of area under the curve in clinical trials with censored follow-up: Application to HIV therapeutic vaccines.

Journal: Statistical methods in medical research

Published: July 05, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026